PS www.ProStocks.com
|
|
| Review By | Subscribe | Neutral | Avoid |
|---|---|---|---|
| Brokers | 1 | 0 | 0 |
| Members | 3 | 1 | 2 |
| IPO Open | Jan 16, 2023 |
| IPO Close | Jan 19, 2023 |
| IPO Price | ₹72 |
| Face Value | ₹10 |
| IPO Size | ₹13.05 Cr |
| Listing At | NSE SME |
| Lot Size | 1600 |
| Reviewer | Recommendation |
|---|---|
| Dilip Davda | May Apply |
Aristo Bio-Tech and Lifescience IPO Reviews, analysis and views by popular members. Read Aristo Bio-Tech and Lifescience Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
| Member | Review |
|---|---|
Gaurav DD dimer  IPO Mentor (700+ Posts, 200+ Likes) |
Subscribe for Listing Gain at Cut-off Price Going with 21 Lots. |
| ipopraveen |
Neutral the issue is fully priced in peer competitors like Dhanuka have 12 - 13% PAT margin whereas aristo is having PAT margin of 1-2% Jan 13, 2023 3:52:29 PM |
| IPOse Dukhi Atma |
Avoid Revenue is decreasing over the years. Also fake promotion is going on in CG messages. So sounds fishy and risky to me. |
| CAhsBlr |
Avoid It is a fully priced IPO. SME is very risky and hence I apply to only those IPOs where more money is left on table. Return of capital is more important than return on capital.
|
| Loy Hus |
Subscribe for Listing Gain at Cut-off Price Looks promising |
| RANJAN NK |
Subscribe for Listing Gain at Upper Price Band Subscribe for huge returns
|
Post Recommendation Manage Recommendations
Note:
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
RHP
